Figures & data
Figure 1 Prevalence of Sickle cell disease in Saudi Arabia. Yellow: Central region of Saudi Arabia, Orange: Eastern region of Saudi Arabia, Green: Southern region of Saudi Arabia, Blue: Western region of Saudi Arabia, Light green: Northern region of Saudi Arabia.
![Figure 1 Prevalence of Sickle cell disease in Saudi Arabia. Yellow: Central region of Saudi Arabia, Orange: Eastern region of Saudi Arabia, Green: Southern region of Saudi Arabia, Blue: Western region of Saudi Arabia, Light green: Northern region of Saudi Arabia.](/cms/asset/3f0dfa53-f8c7-42de-a51f-3d225cc66565/dijg_a_12154823_f0001_c.jpg)
Table 1 Participants’ Demographics (n = 160)
Table 2 Annual Distribution of Admissions, Emergency Department Visits, and Length of Stay
Figure 2 Number of patients by frequency of ED visits. Blue: No ED visits, green: 1–2 ED visits, orange: 3–4 ED visits, yellow: 5–6 ED visits, brown ≥ 7 ED visits.
![Figure 2 Number of patients by frequency of ED visits. Blue: No ED visits, green: 1–2 ED visits, orange: 3–4 ED visits, yellow: 5–6 ED visits, brown ≥ 7 ED visits.](/cms/asset/3175e745-20f1-455f-ab15-e7951ed83f21/dijg_a_12154823_f0002_c.jpg)
Figure 3 Number of patients by frequency of admissions. Blue: No admissions, green: 1–2 admissions, orange: ≥ 3 admissions.
![Figure 3 Number of patients by frequency of admissions. Blue: No admissions, green: 1–2 admissions, orange: ≥ 3 admissions.](/cms/asset/6cffbb1d-594a-4778-aad7-c875d0361d88/dijg_a_12154823_f0003_c.jpg)
Table 3 Participants’ Clinical Characteristics (n = 160)
Table 4 Complications/Comorbidities of Patients with SCD